Lucie Heinzerling
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Treatment of Immune-related Adverse Events Refractory to Standard Therapy and Associated Changes in Immunophenotype (NCT05700565) | Lucie Heinzerling | 2022-01-01 |
Track Lucie Heinzerling automatically
Every clearance here is in the API, with alerts when new ones post.